Skip Navigation
Grant Details

Grant Number: 5R01CA076016-12 Interpret this number
Primary Investigator: Schildkraut, Joellen
Organization: Duke University
Project Title: The Molecular Epidemiology of Ovarian Cancer
Fiscal Year: 2010
Back to top


Abstract

In the current funding period of our study entitled 'The Molecular Epidemiology of Ovarian Cancer' (RO1CA176016, PI: Dr. Schildkraut,), we have studied the relationship between candidate genes in the DNA damage and repair pathway and ovarian cancer risk using data from the North Carolina Ovarian Cancer Study (NCOCS). To date, we have examined the relationship between 53 genes and 652 SNPs in this pathway. The first phase of our study we have identified strong association between genes on the DNA repair pathway and ovarian cancer risk. In this competitive renewal we propose to expand the scope of our Phase 1 genotyping to further investigate genes the DNA repair and apopotosis pathways and to mount a second candidate gene association study. We hypothesize that a subset of the previouslyexamined SNPs in genes with known roles in DNA damage and repair will emerge as risk factors for ovarian cancer, and that newly-examined SNPs in genes within this and related pathways will be associated with risk of ovarian cancer. The proposed study will be designed to optimally accumulate evidence on candidates while simultaneously reducing the false positive rate among included SNPs and minimizing the rate of false negatives. Analyses will examine risk modification across subgroups defined by age, race, body mass index, oral contraceptive use, pregnancy history, histology and other exposures. The ultimate goal is to improve our ability to identify women at genetic risk of ovarian cancer and to design targeted intervention strategies to prevent this fatal disease. To this end, we propose to genotype in 2,075 invasive serous epithelial ovarian cancer cases and 2,075 age-matched controls of European descent to determine the relationship between genetic variants in DNA response and repair and related pathways. We will evaluate the association between over 2,000 SNPs with risk of ovarian cancer. We will access subjects from six independent case-control studies: North Carolina (Dr.Schildkraut), the Mayo Clinic (Dr. Goode), New England (Drs. Terry and Cramer), Pittsburgh (Dr. Ness), Los Angeles (Drs. Pearce and Wu) and Seattle (Dr. Rossing). Further confirmation will be pursued in collaboration with the Ovarian Cancer Association Consortium (OCAC) in the future.

Back to top


Publications

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Authors: Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjr SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N, Ovarian Cancer Association Consortium
Source: J Natl Cancer Inst, 2014 Feb;106(2), p. djt431.
PMID: 24503200
Related Citations

Back to top


Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Authors: Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT, Ovarian Cancer Association Consortium
Source: Cancer Prev Res (Phila), 2013 Aug;6(8), p. 811-21.
EPub date: 2013 Jun 12.
PMID: 23761272
Related Citations

Back to top


Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
Authors: Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, for Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber RP, Ziogas A, Anton-Culver H, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Brinton L, Wentzensen N, Lissowska J, Garcia-Closas M, Massuger LF, Kiemeney LA, Van Altena AM, Aben KK, Berchuck A, Doherty JA, Iversen E, McGuire V, Moorman PG, Pharoah P, Pike MC, Risch H, Sieh W, Stram DO, Terry KL, Whittemore A, Wu AH, Schildkraut JM, Kjaer SK, Ovarian Cancer Association Consortium
Source: Cancer Epidemiol Biomarkers Prev, 2013 May;22(5), p. 880-90.
EPub date: 2013 Mar 5.
PMID: 23462924
Related Citations

Back to top


Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
Authors: Faber MT, Kjr SK, Dehlendorff C, Chang-Claude J, Andersen KK, Hgdall E, Webb PM, Jordan SJ, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, Goodman MT, Ness RB, Modugno F, Edwards RP, Bunker CH, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Cramer DW, Terry KL, Vitonis AF, Bandera EV, Olson SH, King M, Chandran U, Kiemeney LA, Massuger LF, van Altena AM, Vermeulen SH, Brinton L, Wentzensen N, Lissowska J, Yang HP, Moysich KB, Odunsi K, Kasza K, Odunsi-Akanji O, Song H, Pharaoh P, Shah M, Whittemore AS, McGuire V, Sieh W, Sutphen R, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Risch HA, Jensen A, Ovarian Cancer Association Consortium
Source: Cancer Causes Control, 2013 May;24(5), p. 989-1004.
EPub date: 2013 Mar 2.
PMID: 23456270
Related Citations

Back to top


Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
Authors: Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM, Ovarian Cancer Association Consortium
Source: Endocr Relat Cancer, 2013 Apr;20(2), p. 251-62.
EPub date: 2013 Mar 22.
PMID: 23404857
Related Citations

Back to top


Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
Authors: Goode EL, DeRycke M, Kalli KR, Oberg AL, Cunningham JM, Maurer MJ, Fridley BL, Armasu SM, Serie DJ, Ramar P, Goergen K, Vierkant RA, Rider DN, Sicotte H, Wang C, Winterhoff B, Phelan CM, Schildkraut JM, Weber RP, Iversen E, Berchuck A, Sutphen R, Birrer MJ, Hampras S, Preus L, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Song H, Tyrer J, Pharoah PP, Konecny G, Sellers TA, Ness RB, Sucheston LE, Odunsi K, Hartmann LC, Moysich KB, Knutson KL
Source: PLoS One, 2013;8(1), p. e53903.
EPub date: 2013 Jan 30.
PMID: 23382860
Related Citations

Back to top


Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
Authors: Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Kbel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Hgdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA, Australian Ovarian Cancer Study Group and Australian Cancer Study (Ovarian Cancer), Ovarian Cancer Association Consortium
Source: BMC Cancer, 2013 Jan 22;13, p. 28.
EPub date: 2013 Jan 22.
PMID: 23339562
Related Citations

Back to top


Global ovarian cancer health disparities.
Authors: Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM
Source: Gynecol Oncol, 2013 Apr;129(1), p. 258-64.
EPub date: 2012 Dec 22.
PMID: 23266352
Related Citations

Back to top


Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
Authors: Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, Berchuck A, Schildkraut JM
Source: Gynecol Oncol, 2013 Apr;129(1), p. 173-8.
EPub date: 2012 Dec 21.
PMID: 23262379
Related Citations

Back to top


ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Authors: Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, Schildkraut JM, Sutphen R, Tsai YY, Tyrer J, Vierkant RA, Wentzensen N, Yang HP, Terry KL, Tworoger SS
Source: Cancer Causes Control, 2012 Nov;23(11), p. 1805-10.
EPub date: 2012 Sep 8.
PMID: 22961099
Related Citations

Back to top


Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Authors: Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, Brewster W, Anton-Culver H, Gentry-Maharaj A, Ramus SJ, Anderson AR, Brueggmann D, Fasching PA, Gayther SA, Huntsman DG, Menon U, Ness RB, Pike MC, Risch H, Wu AH, Berchuck A, Ovarian Cancer Association Consortium
Source: Lancet Oncol, 2012 Apr;13(4), p. 385-94.
EPub date: 2012 Feb 22.
PMID: 22361336
Related Citations

Back to top


Ovarian cancer risk associated with inherited inflammation-related variants.
Authors: White KL, Schildkraut JM, Palmieri RT, Iversen ES Jr, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, Ramus SJ, Wentzensen N, Yang HP, Garcia-Closas M, Phelan CM, Cunningham JM, Fridley BL, Sellers TA, Goode EL, Ovarian Cancer Association Consortium
Source: Cancer Res, 2012 Mar 1;72(5), p. 1064-9.
EPub date: 2012 Jan 26.
PMID: 22282663
Related Citations

Back to top


Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
Authors: Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Sieh W, Gronwald J, Medrek K, Jakubowska A, Lubinski J, Chenevix-Trench G, AOCS/ACS Study Group, Beesley J, Webb PM, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Edlund CK, Stram DO, Pike MC, Ness RB, Rossing MA, Wu AH
Source: Hum Mol Genet, 2011 Jun 1;20(11), p. 2263-72.
EPub date: 2011 Mar 21.
PMID: 21422097
Related Citations

Back to top


Recreational physical activity and ovarian cancer risk and survival.
Authors: Moorman PG, Jones LW, Akushevich L, Schildkraut JM
Source: Ann Epidemiol, 2011 Mar;21(3), p. 178-87.
PMID: 21296269
Related Citations

Back to top


Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.
Authors: Witt KL, Moorman PG, Kovalchuk O, Holland N, Block G, Andreassen PR
Source: Environ Mol Mutagen, 2010 Oct-Dec;51(8-9), p. 774-80.
PMID: 20740639
Related Citations

Back to top


Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.
Authors: Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, Palmieri RT, Whitaker R, Bentley RC, Marks JR, Berchuck A
Source: PLoS One, 2010 Apr 8;5(4), p. e10061.
EPub date: 2010 Apr 8.
PMID: 20386703
Related Citations

Back to top


Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
Authors: Grant DJ, Moorman PG, Akushevich L, Palmieri RT, Bentley RC, Schildkraut JM
Source: Cancer Causes Control, 2010 Jul;21(7), p. 991-8.
EPub date: 2010 Mar 23.
PMID: 20309725
Related Citations

Back to top


Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
Authors: White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Tsai YY, Kalli KR, Berchuck A, Iversen ES, Hartmann LC, Liebow M, Armasu S, Fredericksen Z, Larson MC, Duggan D, Couch FJ, Schildkraut JM, Cunningham JM, Goode EL
Source: Twin Res Hum Genet, 2010 Feb;13(1), p. 43-56.
PMID: 20158306
Related Citations

Back to top


ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Authors: Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Berchuck A, Moorman PG, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Yang HP, Garcia-Closas M, Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Ziogas A, Brewster W, Anton-Culver H, Australian Ovarian Cancer Study Management Group, Australian Cancer Study (Ovarian Cancer), Pearce CL, Ovarian Cancer Association Consortium (OCAC)
Source: Cancer Epidemiol Biomarkers Prev, 2010 Jan;19(1), p. 245-50.
PMID: 20056644
Related Citations

Back to top


Ovarian cancer risk factors in African-American and white women.
Authors: Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM
Source: Am J Epidemiol, 2009 Sep 1;170(5), p. 598-606.
EPub date: 2009 Jul 15.
PMID: 19605513
Related Citations

Back to top


Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
Authors: Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Krger Kjaer S, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah PD, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M, Australian Ovarian Cancer Study Group
Source: Cancer Res, 2009 Mar 15;69(6), p. 2349-57.
EPub date: 2009 Mar 10.
PMID: 19276375
Related Citations

Back to top


Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
Authors: Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H, Hogdall E, Kjaer SK, Whittemore AS, DiCioccio R, Ramus SJ, Gayther SA, Schildkraut JM, Pharaoh PP, Sellers TA
Source: Cancer Epidemiol Biomarkers Prev, 2009 Mar;18(3), p. 935-44.
EPub date: 2009 Mar 3.
PMID: 19258477
Related Citations

Back to top


Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
Authors: Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JM, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group
Source: Br J Cancer, 2009 Jan 27;100(2), p. 412-20.
EPub date: 2009 Jan 6.
PMID: 19127255
Related Citations

Back to top


Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Authors: Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Edlund CK, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Kjaer SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Ness RB, Pearce CL, Pharoah PD, Pike MC, Ramus SJ, Rossing MA, Song H, Terada KY, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM, Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer Group), Australian Ovarian Cancer Study Group
Source: Cancer Epidemiol Biomarkers Prev, 2008 Dec;17(12), p. 3567-72.
PMID: 19064572
Related Citations

Back to top


Consortium analysis of 7 candidate SNPs for ovarian cancer.
Authors: Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PD, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL, Ovarian Cancer Association Consortium
Source: Int J Cancer, 2008 Jul 15;123(2), p. 380-8.
PMID: 18431743
Related Citations

Back to top


Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
Authors: Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, Fredericksen ZS, Gadre MK, Rider DN, Liebow M, Goode EL
Source: Cancer Res, 2008 Apr 1;68(7), p. 2498-506.
PMID: 18381459
Related Citations

Back to top


Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Authors: Schildkraut JM, Moorman PG, Bland AE, Halabi S, Calingaert B, Whitaker R, Lee PS, Elkins-Williams T, Bentley RC, Marks JR, Berchuck A
Source: Cancer Epidemiol Biomarkers Prev, 2008 Mar;17(3), p. 585-93.
PMID: 18349276
Related Citations

Back to top


Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.
Authors: Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, Berchuck A, Schildkraut JM
Source: Am J Epidemiol, 2008 May 1;167(9), p. 1059-69.
EPub date: 2008 Feb 25.
PMID: 18303003
Related Citations

Back to top


Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
Authors: Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, Halabi S, Calingaert B, Gusberg A, Marks JR, Berchuck A
Source: Cancer Epidemiol Biomarkers Prev, 2007 Mar;16(3), p. 473-80.
PMID: 17372242
Related Citations

Back to top


Analgesic drug use and risk of ovarian cancer.
Authors: Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A
Source: Epidemiology, 2006 Jan;17(1), p. 104-7.
PMID: 16357602
Related Citations

Back to top


Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women.
Authors: Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM
Source: Cancer Causes Control, 2005 Oct;16(8), p. 955-63.
PMID: 16132804
Related Citations

Back to top


Menopausal hormones and risk of ovarian cancer.
Authors: Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A
Source: Am J Obstet Gynecol, 2005 Jul;193(1), p. 76-82.
PMID: 16021062
Related Citations

Back to top


BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Authors: Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G
Source: Gynecol Oncol, 2005 Jun;97(3), p. 807-12.
PMID: 15904951
Related Citations

Back to top


Antidepressant medication use [corrected] and risk of ovarian cancer.
Authors: Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM
Source: Obstet Gynecol, 2005 Apr;105(4), p. 725-30.
PMID: 15802397
Related Citations

Back to top


Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Authors: Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G
Source: Cancer Epidemiol Biomarkers Prev, 2004 Dec;13(12), p. 2141-7.
PMID: 15598772
Related Citations

Back to top


Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Authors: Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT
Source: Am J Obstet Gynecol, 2004 Sep;191(3), p. 733-40.
PMID: 15467532
Related Citations

Back to top


Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Authors: Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A
Source: Clin Cancer Res, 2003 Oct 1;9(12), p. 4396-403.
PMID: 14555511
Related Citations